Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity.

Inhibition of the enzyme catechol-O-methyltransferase (COMT) is an important approach in the treatment of Parkinson's disease. A series of new potent bisubstrate inhibitors for COMT, resulting from X-ray structure-based design and featuring adenosine and catechol moieties have been synthesised. Biological results show a large dependence of binding affinity on inhibitor preorganisation and the length of the linker between nucleoside and catechol moieties. The most potent bisubstrate inhibitor for COMT has an IC50 value of 9 nM. It exhibits competitive kinetics for the SAM and mixed inhibition kinetics for the catechol binding site. Its bisubstrate binding mode was confirmed by X-ray structure analysis of the ternary complex formed by the inhibitor, COMT and a Mg2+ ion.

[1]  I. Lindén,et al.  Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  S. Burley,et al.  X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition. , 2002, Journal of molecular biology.

[3]  G. Waldrop,et al.  A bisubstrate analog inhibitor of the carboxyltransferase component of acetyl-CoA carboxylase. , 2002, Biochemical and biophysical research communications.

[4]  Gerhard Klebe,et al.  De Novo Design, Synthesis, and In Vitro Evaluation of Inhibitors for Prokaryotic tRNA‐Guanine Transglycosylase: A Dramatic Sulfur Effect on Binding Affinity , 2002, Chembiochem : a European journal of chemical biology.

[5]  M. Schlitzer,et al.  Non-thiol farnesyltransferase inhibitors: structure-activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors. , 2002, Bioorganic & medicinal chemistry.

[6]  F. Diederich,et al.  X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity. , 2001, Angewandte Chemie.

[7]  M. Newcomer,et al.  A helical lid converts a sulfotransferase to a dehydratase , 2001, Nature Structural Biology.

[8]  Richard A. Dixon,et al.  Structures of two natural product methyltransferases reveal the basis for substrate specificity in plant O-methyltransferases , 2001, Nature Structural Biology.

[9]  S. Hubbard,et al.  Mechanism-based design of a protein kinase inhibitor , 2001, Nature Structural Biology.

[10]  P Schelling,et al.  Nucleoside binding site of Herpes simplex type 1 thymidine kinase analyzed by X‐ray crystallography , 2000, Proteins.

[11]  F. Diederich,et al.  Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT). , 2000, Chemistry.

[12]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[13]  D. Crich,et al.  One Pot Selective 5′-Oxidation/Olefination of 2′-Deoxynucleosides , 1999 .

[14]  H. Waldmann,et al.  Synthesis and In Vitro Evaluation of the Ras Farnesyltransferase Inhibitor Pepticinnamin E. , 1998, Angewandte Chemie.

[15]  G. Schulz,et al.  The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis. , 1998, Journal of molecular biology.

[16]  W. Oertel,et al.  Catechol-O-methyltransferase inhibition with tolcapone reduces the"wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients , 1997, Neurology.

[17]  J. Larsen,et al.  Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial , 1997 .

[18]  C. Adler,et al.  Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations , 1997, Neurology.

[19]  Paul R. Gerber,et al.  MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..

[20]  V. Villeret,et al.  Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. , 1995, Biochemistry.

[21]  Anders Liljas,et al.  Crystal structure of catechol O-methyltransferase , 1994, Nature.

[22]  B. Wilk.  A CONVENIENT PREPARATION OF ALKYL NITRILES BY THE MITSUNOBU PROCEDURE , 1993 .

[23]  R. Ireland,et al.  An improved procedure for the preparation of the Dess-Martin periodinane , 1993 .

[24]  J. Coward,et al.  Synthesis of complex 6'-alkynyl-6'-dethia nucleoside analogs of S-adenosylhomocysteine as potential inhibitors of methyltransferases , 1990 .

[25]  A. D. Broom.  Rational design of enzyme inhibitors: multisubstrate analogue inhibitors. , 1989, Journal of medicinal chemistry.

[26]  D. Cram,et al.  The design of molecular hosts, guests, and their complexes , 1988, Science.

[27]  A. Matsuda,et al.  Synthesis of 8, 6'-Cyclo-6'-deoxyhexofuranosyladenines : Adenosines Fixed in an Anti-conformation (Nucleosides and Nucleotides. LXVI) , 1986 .

[28]  E. Schlimme,et al.  Darstellung und Konformationszuordnung einiger 5'-homologer Adenosinderivate , 1984 .

[29]  C. Danzin,et al.  Synthesis and biochemical properties of chemically stable product analogues of the reaction catalyzed by S-adenosyl-L-methionine decarboxylase. , 1982, Journal of medicinal chemistry.

[30]  M. Prada,et al.  Rapid and Sensitive Single‐Step Radiochemical Assay for Catechol‐O‐Methyltransferase , 1982, Journal of neurochemistry.

[31]  J. Montgomery,et al.  The use of the wittig reaction in the modification of purine nucleosides , 1974 .

[32]  S. Wolfe,et al.  Five-membered rings. II. Inter and intramolecular reactions of simple amines with N-substituted phthalimides. Methylamine as a reagent for removal of a phthaloyl group from nitrogen , 1970 .

[33]  J. G. Moffatt,et al.  Sulfoxide-Carbodiimide Reactions. I. A Facile Oxidation of Alcohols , 1965 .